Let's start with Pfizer first.
Pfizer has been down since mid of December 2022.
And now it is on interesting area (see on the chart)
In my view, area of $ 42.74 to $ 43.52 will be critical.
Next week Pivot Point will be at $ 44.24, if the price can stand above its weekly Pivot Point then a potential reversal may occur.
If we look at the weekly chart, EMA200 Weekly has been survived by the last downfall of PFE on October 2022.
MACD have shown a small bullish divergence.
Maybe an Earning Report can boost
Let's see.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。